Winch Advisory Services, LLC Rigel Pharmaceuticals Inc Transaction History

Winch Advisory Services, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $780 - $1,077	-300 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$2.83 - $4.11 $849 - $1,233	300 New	300 $1,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.91B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Winch Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Winch Advisory Services, LLC with notifications on news.